Electroconductivity of Saliva as a Diagnostic Tool for Dry Eye Disease: A Case-Control Study
Translational Vision Science & Technology · 2025
DOI: 10.1167/tvst.14.8.2 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Yung-Kang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Chiayi Chang Gung Memorial Hospital, Puzi City, Taiwan. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Saliva. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the diagnostic potential of body fluid electroconductivity for dry eye disease (DED) and compare its accuracy with commonly used DED tests.
Methods
Individuals with dry eye (n = 36) and controls (n = 26) were enrolled in this case-control prospective study. Electroconductivity measurements were performed on blood, serum, tears, urine, and saliva. Dry eye assessments included tear film breakup time (TBUT) and Schirmer test (Schirmer), with symptoms evaluated using the Ocular Surface Disease Index (OSDI). Blood and urine analyses were performed to assess the baseline systemic profiles of both groups.
Results
Among all body fluids, saliva (saliva electroconductivity [ESaliva]) showed the most significant differences in electroconductivity between controls and dry eye individuals (2514.02 ± 329.18 vs. 3262.00 ± 992.47 µS/cm, P < 0.001). ESaliva showed robust diagnostic performance (area under the curve [AUC] = 0.800), comparable to TBUT (AUC = 0.693, P = 0.103) and superior to Schirmer (AUC = 0.536, P < 0.001). OSDI showed a moderate correlation with ESaliva (r = 0.43, P < 0.001), representing the strongest association, followed by TBUT (r = -0.26, P = 0.004) and Schirmer (r = -0.09, P = 0.313). Cross-validation procedure identified ESaliva cutoffs of 2373 µS/cm (95% confidence interval [CI], 2340-2456) for low-to-moderate and 2880 µS/cm (95% CI, 2845-2931) for moderate-to-high DED risk. Net reclassification improvement and integrated discrimination improvement analyses confirmed ESaliva's superior predictive ability. A single cutoff of 2880 µS/cm yielded 64% sensitivity and 89% specificity for DED prediction.
Conclusions
ESaliva effectively distinguishes patients with DED and exhibits superior diagnostic performance. Translational Relevance: ESaliva: offers a noninvasive and self-assessable tool for DED diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, Chiayi Chang Gung Memorial Hospital, Puzi City, Taiwan.
- Department of Ophthalmology, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
- Department of Ophthalmology, Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
- Department of Statistics and Data Science, UCLA, Los Angeles, CA, USA.
- Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Chiayi Chang Gung Memorial Hospital, Puzi City, Taiwan.
- Department of Neurosurgery, Chiayi Chang Gung Memorial Hospital, Puzi City, Taiwan.
Zitieren
APA
Chen, Y. K., Lai, C. H., Wu, W. C., Wang, C. H., Lin, K. M., Chen, N. N., Yang, J. T., & Wu, P. L. (2025). Electroconductivity of Saliva as a Diagnostic Tool for Dry Eye Disease: A Case-Control Study. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.8.2
Vancouver
Chen YK, Lai CH, Wu WC, Wang CH, Lin KM, Chen NN, et al. Electroconductivity of Saliva as a Diagnostic Tool for Dry Eye Disease: A Case-Control Study. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.8.2
BibTeX
@article{Chen2025,
author = {Chen, Yung-Kang and Lai, Chien-Hsiung and Wu, Wei-Chi and Wang, Chi-Hua and Lin, Ko-Ming and Chen, Nan-Ni and Yang, Jen-Tsung and Wu, Pei-Lun},
title = {Electroconductivity of Saliva as a Diagnostic Tool for Dry Eye Disease: A Case-Control Study},
journal = {Translational Vision Science & Technology},
year = {2025},
doi = {10.1167/tvst.14.8.2}
}
EUVIMED